AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

Search

Haleon PLC

Cerrado

SectorSanidad

404.3 0.17

Resumen

Variación precio

24h

Actual

Mínimo

401.4

Máximo

405

Métricas clave

By Trading Economics

Ingresos

-254M

231M

Ventas

-21M

2.8B

P/B

Media del Sector

25.994

51.198

BPA

0.042

Rentabilidad por dividendo

1.59

Margen de beneficios

8.373

Empleados

24,561

EBITDA

-317M

399M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+10.28% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.59%

2.40%

Próximas Ganancias

31 jul 2025

Próxima Fecha de Ex Dividendo

14 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

3.4B

37B

Apertura anterior

404.13

Cierre anterior

404.3

Noticias sobre sentimiento de mercado

By Acuity

24%

76%

56 / 380 Clasificación en Healthcare

Haleon PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 abr 2025, 09:37 UTC

Adquisiciones, fusiones, absorciones

Haleon Acquires Chinese JV in $264 Million Deal

19 mar 2025, 07:34 UTC

Adquisiciones, fusiones, absorciones

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 mar 2025, 17:26 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Dispose of Remaining Shareholding in Haleon

30 may 2025, 13:47 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Consumer Health Sector Has Room for More Dealmaking -- Market Talk

30 abr 2025, 08:33 UTC

Charlas de Mercado
Ganancias

Haleon's Vitamins & Supplements Business Weakness in Focus Among Results -- Market Talk

30 abr 2025, 06:09 UTC

Ganancias

Haleon Expects Macroeconomic Environment to Remain Challenging, Uncertain

30 abr 2025, 06:09 UTC

Ganancias

Haleon Continues to Deliver Against Capital Allocation Priorities

30 abr 2025, 06:08 UTC

Ganancias

Analysts Saw Haleon 1Q Organic Revenue Growth at 5.1%

30 abr 2025, 06:03 UTC

Ganancias

Haleon Sees 2025 Adjusted Operating Profit Growth Ahead of Revenue Growth

30 abr 2025, 06:03 UTC

Ganancias

Haleon Sees 2025 Organic Revenue Growth of 4%-6%

30 abr 2025, 06:03 UTC

Ganancias

Haleon Backs 2025 View

30 abr 2025, 06:03 UTC

Ganancias

Haleon 1Q Rev GBP2.85B

30 abr 2025, 06:01 UTC

Ganancias

Haleon 1Q Organic Revenue Growth up 3.5%

29 abr 2025, 19:47 UTC

Ganancias

Pfizer Shares Rise on CEO's Optimism on Threatened Drug Tariffs -- Barrons.com

15 abr 2025, 09:03 UTC

Adquisiciones, fusiones, absorciones

Haleon: Deal Expected to Close Within Next Three Mos

15 abr 2025, 09:03 UTC

Adquisiciones, fusiones, absorciones

Haleon Has Bought Last 12% Interest for GBP200M

15 abr 2025, 09:02 UTC

Adquisiciones, fusiones, absorciones

Haleon Bought 33% interest in December 2024

15 abr 2025, 09:02 UTC

Adquisiciones, fusiones, absorciones

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical from Tianjin Pharmaceutical Da Ren Tang

15 abr 2025, 09:01 UTC

Adquisiciones, fusiones, absorciones

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical

18 mar 2025, 16:58 UTC

Adquisiciones, fusiones, absorciones

Haleon Intends to Cancel Purchased Ordinary Shares

18 mar 2025, 16:57 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 mar 2025, 16:56 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 mar 2025, 16:56 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 mar 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

Haleon Takes Note of Announcement

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: This Is Subject to Customary Closing Conditions

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Bookbuilding Period Will Commence Immediately

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

Comparación entre iguales

Cambio de precio

Haleon PLC previsión

Precio Objetivo

By TipRanks

10.28% repunte

Estimación a 12 Meses

Media 444.75 GBX  10.28%

Máximo 502 GBX

Mínimo 360 GBX

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Haleon PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

12 ratings

9

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

56 / 380 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.